Profile
| Role | Insider |
|---|---|
| Notability | 20/100 |
Board memberships
- MBX Biosciences, Inc.
Updated Jul 16, 2026
Heron Patrick J has filed 4 SEC Form 4 filings across 3 companies in the last 90 days — buying. Lifetime open-market purchases: $21.00M.
| Role | Insider |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-06-10 | ARQT | Arcutis Biotherapeutics, Inc. | A — Grant or award | 5.8K | $0.00 | |
| 2026-01-27 | MIRM | Mirum Pharmaceuticals, Inc. | P — Open-market purchase | 131.4K | $68.48 | $9.00M |
| 2026-01-27 | MIRM | Mirum Pharmaceuticals, Inc. | J — Other acquisition / disposition | 159.3K | — | |
| 2025-09-26 | MBX | MBX Biosciences, Inc. | P — Open-market purchase | 666.7K | $18.00 | $12.00M |
Heron Patrick J is a corporate insider — currently tracked as Insider of Mirum Pharmaceuticals, Inc. (MIRM). InsiderAlpha tracks every SEC Form 4 filing in real time.
4 primary Form 4 filings in the last 90 days, covering 3 companies.
Recorded transactions: 2 open-market purchases ($21.00M) and 0 open-market sales () across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Heron Patrick J profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.